Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russ Chess-Williams

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Scientific Reports|May 20, 2020
A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapyJordan Hart, Briohny Spencer, Catherine M McDermott, et al.
Journal of Clinical Medicine|October 14, 2022
Drivers of Radioresistance in Prostate CancerLiam King, Nijole Bernaitis, David Christie, et al.
European Journal of Pharmacology|December 28, 2020
Quinazoline alpha-adrenoreceptor blockers as an adjunct cancer treatment: From bench to bedsideLiam King, David Christie, Wendy Dare, et al.
Archives of Toxicology|May 24, 2020
Hypersensitivity of bladder low threshold, wide dynamic range, afferent fibres following treatment with the chemotherapeutic drugs cyclophosphamide and ifosfamideKylie A Mills, Eleanor J West, Luke Grundy, et al.
Journal of Pharmacological Sciences|August 25, 2018
α<sub>1L</sub>-adrenoceptors mediate contraction of human erectile tissueBeverley J Davis, Christopher R Chapple, Donna J Sellers, et al.
The Journal of Urology|January 24, 2012
Effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viabilityCatherine McDermott, Russ Chess-Williams, Gary D Grant, et al.
American Journal of Physiology. Renal Physiology|June 14, 2018
NKA enhances bladder-afferent mechanosensitivity via urothelial and detrusor activationLuke Grundy, Russ Chess-Williams, Stuart M Brierley, et al.
The Prostate|March 15, 2026
A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP-00)Liam D King, David Christie, Daniel Cehic, et al.
International Journal of Molecular Sciences|August 19, 2016
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersMallory Batty, Rachel Pugh, Ilampirai Rathinam, et al.
Toxins|August 13, 2016
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosaSusan Hall, Catherine McDermott, Shailendra Anoopkumar-Dukie, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|May 20, 2020
A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapyJordan Hart, Briohny Spencer, Catherine M McDermott, et al.
Journal of Clinical Medicine|October 14, 2022
Drivers of Radioresistance in Prostate CancerLiam King, Nijole Bernaitis, David Christie, et al.
European Journal of Pharmacology|December 28, 2020
Quinazoline alpha-adrenoreceptor blockers as an adjunct cancer treatment: From bench to bedsideLiam King, David Christie, Wendy Dare, et al.
Archives of Toxicology|May 24, 2020
Hypersensitivity of bladder low threshold, wide dynamic range, afferent fibres following treatment with the chemotherapeutic drugs cyclophosphamide and ifosfamideKylie A Mills, Eleanor J West, Luke Grundy, et al.
Journal of Pharmacological Sciences|August 25, 2018
α<sub>1L</sub>-adrenoceptors mediate contraction of human erectile tissueBeverley J Davis, Christopher R Chapple, Donna J Sellers, et al.
The Journal of Urology|January 24, 2012
Effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viabilityCatherine McDermott, Russ Chess-Williams, Gary D Grant, et al.
American Journal of Physiology. Renal Physiology|June 14, 2018
NKA enhances bladder-afferent mechanosensitivity via urothelial and detrusor activationLuke Grundy, Russ Chess-Williams, Stuart M Brierley, et al.
The Prostate|March 15, 2026
A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP-00)Liam D King, David Christie, Daniel Cehic, et al.
International Journal of Molecular Sciences|August 19, 2016
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersMallory Batty, Rachel Pugh, Ilampirai Rathinam, et al.
Toxins|August 13, 2016
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosaSusan Hall, Catherine McDermott, Shailendra Anoopkumar-Dukie, et al.
Pageof 8